Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors
Go back to Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 33.50 -0.17 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.67 | 52 Week High | $5.17 | |||
| Open | $33.67 | 52 Week Low | $0.94 | |||
| Day High | $34.75 | P/E | N/A | |||
| Day Low | $32.77 | EPS | $0.00 | |||
| Volume | 1,571,667 | |||||
